Pharmacokinetics of coadministration of levothyroxine sodium and alendronate sodium new effervescent formulation
作者: H. G. BoneM. A. WalterM. E. HurleyS. Epstein
作者单位: 1Michigan Bone & Mineral Clinic
2Mission Pharmacal Company
3Hurley Consulting Associates Ltd.
4Icahn School of Medicine at Mt. Sinai
刊名: Osteoporosis International, 2017, Vol.28 (5), pp.1745-1752
来源数据库: Springer Journal
DOI: 10.1007/s00198-017-3941-3
关键词: AlendronateBisphosphonateDrug interactionLevothyroxinePharmacokinetics
英文摘要: No clinically important pharmacokinetic interference of alendronate occurred between a new effervescent formulation of alendronate and levothyroxine when coadministered. The combination does not materially affect levothyroxine absorption.
原始语种摘要: No clinically important pharmacokinetic interference of alendronate occurred between a new effervescent formulation of alendronate and levothyroxine when coadministered. The combination does not materially affect levothyroxine absorption.
全文获取路径: Springer  (合作)
分享到:
来源刊物:
影响因子:4.039 (2012)

×
关键词翻译
关键词翻译
  • 相互酌 给影响
  • effervescent 起泡的
  • formulation 配方
  • interference 干涉
  • clinically 临床上
  • sodium 
  • materially 物质上
  • affect 给影响
  • interaction 给影响
  • absorption 吸收
  • combination 聚形